CTL诱导及杀伤实验
Survivin表位肽诱导CTL免疫学效应及杀瘤效应研究
( 福建 省肿 瘤 医院肿 瘤免疫 研 究 室 福建 医科 大 学教 学 医院 , 州 301) 福 504
中 国 图书 分 类 号 R 9 .2 31 1 文献标识码 A 文章编vvn d f e e t e M eh d : h bly o rd cn N 7 a d kl n mo e fC兀|n u e y u ig hg —  ̄nt e t e s 2 ,n ii- e v d p p d . t o s T ea i t f o u ig I 一 ii gt rc l o i i i p F n l u l id c d b sn ih a i p pi 、 8 i — y d tr d aea i i e t e S 2 3 a d lw-  ̄ nt e i e S 89 rs e t eyw r a ue y u ig E I P T me o d L e me it- f nt p p d V 3 l n o a i p pt V8 6 e p c v l e eme s rd b s L S O t da DH la ea sy. y i y d i n h n re a e s s
wyo ua r i i u o o i l Tahn o i lfFj nMei lU i rt, ahu3 0 1 , h a r fFj nPo n a T m r s t , eci H s t ua dc nv sy F zo 5 04 C i i v cl H pa g pao i a ei n
M C工限 制方 式 杀 伤 Sr v H tv i ti n阳性 细 胞 , 效 靶 比为 5 :、5 11 . : 时 的 杀 伤 率 分 别 为 (2 4 在 0 12 :、25 1 6 .0±5 1) 、4 . -23 ) 、 .6 % (4 04 .2 % - (65 ±10 ) 2 .3 .7 %和 (34 4 7 ) 、2 .642 6 ) 、 1 .3415 ) , 著 高 于 阴性 对 照 组 :5 5 0 1 ) 、47 . 3 .2± .6 % (5 1 .4 % (5 8 .7 % 显 - - ( .94 .6 % ( . 0± - 6 03 ) 、2 9 400 ) ; 低 亲 和 力 表 位 肽 S 蹲9 导 的免 疫 细 胞 对 靶 细 胞 没 有 明 显 的 杀 伤 作 用 。 结 论 :uv i表 位 肽 负 载 .2 % ( .3 .7 % 而 - v 6 诱 Srin v
猪圆环病毒2型鸡痘病毒活载体疫苗诱导的CTL杀伤活性检测
龄- 1 - 3周龄小 猪 的一种 传染病 , 发病猪 组织 中分离 从
收 稿 日期 : 0 0 0 — 1 2 1 — 6 2
基 金 项 目 : 岛农 业 大 学 高层 次人 才基 金 ( 3 5 0 青 60 i) 作 者 简 介 : 晓 冰 ( 9 4 , , 西晋 城 人 , 教 授 , 士 , 秦 17 一) 女 山 副 博 主要 从 事 分 子 病 毒 学研 究 。
性 最 高 达 6 . 0 ± 2 6 1 ( 靶 比 5 6 05 . 7 效 0:1 和 3 . 7 ± 2 8 3 ( 靶 比 2 ) 88 0 . 8 效 5:1 显 著 高 于 对 照 组 ( < ), P
00 )说 明 v .1。 UTA P — RF ORF — 10 2 1可 以诱 导 猪 产 生 高 水 平 的 特 异 性 细 胞 毒 性 T 淋 巴 细 胞 ( TL 杀 伤 活 性 , C )
到猪 圆 环 病 毒 2型 ( oc ec cv u y e2 C - P ri i o i stp ,P V n r r
2, ) 故认为 它是该病 的病 原 。许 多研 究 已确定 P V 2 C -
对P MW S 发 生 起 着 重 要 的 作 用 D2。 且 , C 2 的 ቤተ መጻሕፍቲ ባይዱ 而 3 P V一
中图 分 类 号 : 8 2 6 9 2 ¥ 5 . 5 . 文献标识码 : A
文 章 编 号 :0 7 5 3 ( 0 1 0 —0 90 1 0 — 0 8 2 1 ) 10 0 — 6
断 奶 仔 猪 多 系 统 衰 竭 综 合 征 ( ot a ig P s wenn -
mutsse c at gsn rmeP l-ytmi w s n y do , MW S 是 影 响 8周 i i )
细胞毒性T淋巴细胞生物杀伤效应的检测方法
细胞毒性T淋巴细胞生物杀伤效应的检测方法作者:王政, 田菲菲, 刘丁, 吕凤林【关键词】 T淋巴细胞生物杀伤细胞毒性细胞介导的免疫效应在机体抗感染免疫、抗肿瘤免疫、移植排斥效应和自身免疫性疾病发生机制中发挥重要作用, 主要效应细胞之一为细胞毒性T淋巴细胞(Cytotoxic T lymphoclyte, CTL)。
近年来, 基于CTL特异性表位的多肽疫苗已经成为研究热点之一, CTL的活化及对靶细胞的杀伤效应成为衡量疫苗质量的重要因素之一。
目前已经报道许多新的评价CTL活性及其杀伤效应的方法, 现就此做一综述。
1 单个细胞水平测定CTL活性目前一般常用的有产生细胞因子的细胞记数法和有限稀释分析法(LDA)。
活化的T淋巴细胞可分泌一些功能性的细胞因子, 如IL2、IFNγ、TNFα等, 由于分泌不同种类细胞因子可以区分不同免疫功能的记忆细胞或效应细胞, 这样可以在体外评价外周血单个核细胞(PBMC)中抗原特异性T细胞的数量和功能状态。
目前常用的检测细胞因子的方法如ELISA、ELISPOT、PCR/RT PCR及细胞内因子检测等。
1.1 有限稀释分析法(Limiting dilution analysis, LDA) 该方法是迄今应用较广泛的定量分析系统[1]。
LDA 法使我们能够详细了解免疫反应动力学和记忆CTL(Memory CTL, mCTL) 细胞亚群的细胞周期[2], 也是对pCTL和mCTL亚群细胞表面的激活标志物进行研究的良好方法。
但此方法也存在缺点, 主要是: (1)在LDA条件下, 深入刺激会使效应CTL(eCTL)细胞加快凋亡[3], 使CTL活性测定值变动较大, 对eCTL细胞数量不能测定或测定值偏低。
(2)实验较繁琐, 因为在实验之前, 首先需要将淋巴细胞表面表达的CD分子, 如CD44或CD62L进行染色, 再用FACS法分类筛选, 然后在LDA条件下培养6 d; 这样就会造成T细胞数量损失, 特别是在活化状态进行筛选和分离时。
CTL诱导及杀伤实验
一、抗原肽诱导CTL制备1.PBMCs were separated from the whole blood of HLA-A2+ healthy controls. PBMCs (2 x106/ml) were cultured with each of the HLAA* 0201 refolding peptides at a concentration of 10 uM in RPMI 1640 medium containing 10% FCS and 20 U/ml recombinant human IL-2 (rhIL-2) in 24-well culture plate. Half of the medium was changed at day 4 with supplementation of rhIL-2 at 20 U/ml. At day 7, cells were harvested and tested for the presence of peptide-specific CD8+ T cells by an IFN-γrelease ELISPOT assay.---------------Zhou M, Xu D, Li X, Li H, Shan M, Tang J, Wang M, Wang FS, Zhu X,Tao H et al: Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J Immunol2006, 177(4):2138-2145.2. PBMCs were separated from heparinized venous blood by Ficoll-Hypaque density gradient centrifugation from HLAA*0201 normal donors and HCC patients. DCs were generated from peripheral blood monocytes as described by Romani. Briefly, PBMCs were seeded into six-well culture plates containing 3 ml RPMI-1640 and 10% FCS at5–10x106/well. Plates were incubated in a 37o C incubator for 2 h, then the non-adherent cells were removed and the adherent cells were cultured at 37o C in RPMI-1640 supplemented with 10% FCS, 1000 U/mlhuman recombinant GM-CSF and 500 U/ml human recombinant IL-4. All T cell stimulation was with day 7 DCs. As described below, DCs were matured with lipopolysaccharide (LPS) on day 6 and HCA587 antigen was added for effective processing at this time.Day 6 DCs were resuspended in RPMI-1640 with 1000 U/ml GM-CSF, 500 U/ml IL-4 and 10 ng/ml LPS and incubated at 37 o C. After 24 h cultivation the DCs were collected, washed and pulsed with 10 m g/ml HCA587 peptide for 3 h at 37 o C. The DCs were washed twice for the following stimulation.CD8+T cells were isolated by positive selection with CD8-Dynal immunomagnetic beads according to the manufacturer’s instructions. After washing, CD8+T cells were co-cultured with HCA587 peptide-loaded DCs in 2 ml RPMI-1640 medium supplemented with 10% AB serum, recombinant human IL-2(10 ng/ml) and IL-6 (500 U/ml). Seven days later, the cultured T cells were restimulated with freshly prepared peptide-pulsed DCs and cultured for another 7 days. After four consecutive rounds of stimulation, cultures were tested for the presence of HCA587-specific CTLs.----------- Li B, Wang Y, Chen J, Wu H, Chen W: Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587. Clin Exp Immunol2005, 140(2):310-319.3.Generation of CTLs in PBMCs from healthy donors:Dendritic cells (DCs) have the unique capacity of activating naive T cells and initiating primary T-cell response. Antigen-specific T-cell responses from peripheral blood mononuclear cells (PBMCs) can be elicited with antigenic peptide-pulsed autologous DCs. We obtained PBMCs from the buffy coat of heparinized whole blood samples of healthy donors by density gradient centrifugation on the Histopaque 1077. These cells were resuspended in serum-free RPMI 1640 and allowed to adhere to six well plates at a final concentration of 1 x 107cells/3 ml/ well. After 2 h of incubation at 37°C, non-adherent cells were gently removed with warm medium by gently pipetting. The non-adherent cells (effector lymphocytes) were cryopreserved in FCS supplemented by 10% DMSO. The resultant adherent cells containing DCs were cultured in medium supplemented with 800 U/ml GMCSF and 1,000 U/ml IL-4 in 37°C/5% CO2. Every 2 days, one-half of the medium was replaced by fresh medium containing a double concentration of GM-CSF and IL-4 as indicated above. On day 5, 10 ng/ml of recombinant human tumor necrosis factor a (TNF-a) was added to the medium to induce phenotypic and functional maturation of DCs. After 48 h, DCs were pulsed with 20 ug/ml peptide in the presence of 3 ug/ml b2- microglobulin at 37°C for 3 h and irradiated at 30 Gy before use. The thawed 2 x106 of non-adherenteffector lymphocytes were cocultured with 2 x105peptidepulsed irradiated autologous DCs in a 24-well plate in the presence of 10 ng/ml recombinant human interleukin-7 (IL-7). After 7 days, lymphocytes were restimulated with peptide-pulsed autologous PBMCs in medium containing 10 ng/ml IL-7 and 20 U/ml IL-2. About 20 U/ml of IL-2 was added 24 h later at regular intervals, 2 days after each restimulation. Lymphocytes were restimulated each week in the same manner. On the seventh day, after the three rounds of restimulation, cells were harvested and tested by ELISPOT assay.--------------An altered peptide ligand for nave cytotoxic T lymphocyte epitope of TRP-2(180–188) enhanced immunogenicity.Cancer Immunol Immunother (2007) 56:319–329 第三军医大吴玉章4.Generation of CTLs in healthy donorsDendritic cells are characterized by the unique capacity to activate naive T cells and initiate primary T-cell response. Antigen-specific T-cell responses from peripheral blood mononuclear cells (PBMCs) can be elicited with antigenic peptide- or protein-pulsed autologous DCs. Here, PBMCs were isolated from whole blood of 11 healthy HLA-A2.1_ volunteer donors by Ficoll/Hypaque density gradient centrifugation. Human peripheral blood monocyte-derived DCs were generated as previously described by us. On day 5 of culture, 10 ng/mL recombinanthuman tumor necrosis factor was added to the medium to induce phenotypic and functional maturation. Then, 48 hours later, DCs were pulsed with 20 ug/mL peptide in the presence of 3 ug/mL B2-microglobulin at 37°C for 3 hours and irradiated at 30 Gy before use. Peripheral blood lymphocytes (PBLs, 2 x106) were cocultured with 2 x 105 peptide-pulsed irradiated autologous DCs in a 24-well plate in the presence of 10 ng/mL recombinant human interleukin-7. The next day, recombinant human IL-10 was added to the culture medium, to give a final concentration of 10 ng/mL. After 7 days, lymphocytes were restimulated with peptide-pulsed irradiated autologous DCs in medium containing 10 ng/mL IL-7 and 10 ng/mL IL-10, and then supplemented with 20 IU/mL IL-2 24 hours later. Lymphocytes were restimulated each week in the same manner. At 7 days after the fourth round of restimulation, cells were harvested and tested by ELISPOT assay, cytotoxicity assay, and tetramer staining. CD8T lymphocytes were purified by CD4_ cell–negative depletion using human CD4 microbeads. ---------Wang B, Chen H, Jiang X, Zhang M, Wan T, Li N, Zhou X, Wu Y, Yang F, Yu Y et al: Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.Blood2004, 104(1):200-206.第二军医大曹雪涛5. 抗原肽诱导CTL制备:密度梯度离心法分离经EDAT抗凝的静脉血中的外周血单个核细胞(peripheral blood mononuclear cells,PBMC),分离得到的PBMC种于6孔细胞培养板,在含10%FCS的RPMI1640培养基中,37℃5%CO2孵育1.5h。
抗原冲击致敏树突状细胞诱导特异性CTL杀伤Lovo细胞实验研究
1 1材料 与试剂 .
大肠癌 细胞 株 Lv oo具有 肠癌 细
LL一 谷氨酰胺的 R M 0培养基中培养。 P I6 1 4
12 3静脉 血 D s的体外 培 养 .. C 取去 除 T细胞 的 静脉 血 M C 留取 部 分作 为 对 照 组 用 流式 细 胞 N s, 仪检 测分化 前 细 胞 表 型 , 余 加 培养 液 调 整 细 胞 其
异 性杀 伤效应 , D 为 C疫 苗在 直肠癌 免疫 中 的临床 应 用提供 实验依 据 。
1 材料 与方 法
龙 毛柱滤 过法 得 到 分 离 纯 化 的 T 细胞 。在 含 1 0
%的胎牛血清、0 U l 10I/m 链霉素、0 /m 青 10I U l
霉素 、 0 mo L二 琉 基 乙 醇 和 1X1 mo 5×1 l / 0 l /
T l p oye, T ) , m h ct C L 观察 C L对 L v y T oo细 胞 的特
c a clM C )和 T细胞分离 : l r es N s e 抽健康 自愿者静
脉血 , i l分 离 得 到 MN s, s—N 1裂解 Fc 1 o C HC
红 细胞 , 置 2 静 h轻 吸 未 黏 附 的 细 胞悬 液 , 用 尼 采
Lv oo细胞 的杀伤 作 用。结 果 冻融抗 原致敏 D C激 活 C L的能 力显 著 高于 未致 敏 的 D s组 , T C 两组 C L Ts
对 Lv oo细胞 的杀 伤率 差异 有统计 学 意义 (09 v 47 , 00 )。结 论 5 .% s .% P< .5 2
状 细胞后 活化 C L 有抗肿 瘤 活性 。 T s,
・
1 8・ 2
柳 州 医 学 2 0年 第 2 01 3卷 第 4期
靶细胞杀伤实验:LDH法
靶细胞杀伤实验:LDH法
一、效应细胞的制备
激惹5天后,于无菌条件下取出受鼠引流的腹股沟淋巴结,100目钢网研磨,调整细胞浓度为2×107.ml-1。
台盼蓝色要求存活率>95%。
二、靶细胞的制备
P815细胞株系DBA/2小鼠的肥大细胞瘤细胞株。
连续传代培养,调整细胞浓度为2×105/ml或3.33×105/ml(加入α-Lyt2 mAb时的靶细胞浓度),台盼蓝染色成活率>95%。
三、LDH释放法测定CTL的功能
按表1加样于96孔培养板中,设3个复孔。
混匀置二氧化碳培养箱中孵育4h。
室温离心,用微量加样器每孔取上清液100μl,送全自动生化分析仪测定每孔的LDH含量。
表1 LDH释放法测定CTL活性的加样情况(μl)
分组效应细
胞靶细
胞
α-Lyt2 m
Ab
1% Triton X-1
00
完全培养
基
自然释放
孔
100 100
最大释放
孔
100 100
实验孔1 100 100
实验孔2 100 60①40
注:靶细胞浓度为3.33×105/ml
四、计算CTL活性
特异杀伤率(%)=(实验孔LDH值-自然释放孔LDH值)/(最大释放孔LDH值-自然释放LDH 值)
五、统计学处理
DTH的测定,4组间比较采用方差分析,两组比较采用q检验。
对于CTL的特异杀伤率,先进行百分数的平方根反正弦转换后采用方差分析进行4组间比较,两两比较采用q检验。
CTL病毒截留技术的原理是什么
CTL病毒截留技术的原理是什么?(昆明国防医院肝病科)由于乙肝是一种很难治的疾病,很多人治疗多年,甚至花光了家里所有的积蓄,也没能把自己的乙肝治好。
因此,当CTL病毒截留技术推出的时候,很多人提出疑问:到底CTL病毒截留技术治疗乙肝的原理是什么,它和传统疗法有什么不同?昆明国防医院的医生指出,CTL病毒截留技术的原理我们分析如下:一、CTL病毒截留技术的原理—操作方法原理:CTL病毒截留技术是通过上新型的非玻璃放电技术产生CTL来诱导、激活血液中的各种细胞成分,并通过血液的流动来触发人体系列免疫应答反应,产生杀灭肝炎病毒的各种免疫细胞和抗病毒因子,从而杀灭和清除肝炎病毒。
治疗时,抽出患者50-100ml血液,在体外用原装进口医用CTL高精密医疗治疗仪器打入特定浓度的CTL,然后再回输到体内。
因为CTL的氧化性很强,在几微秒内就会和血液内的物质发生化学反应,产生各种免疫细胞和抗病毒因子,在清除肝炎病毒的同时还能改善肝脏供氧,利于受损肝细胞的修复,实现了治疗与养护同步。
据大量临床数据证实:CTL病毒截留技术治疗一至三个月就能达到干扰素治疗一年的效果,而且还避免了传统抗病毒药物的毒副性和停药反弹的弊病。
二、CTL病毒截留技术的原理—作用机理:1、免疫杀伤作用:激活机体免疫系统,产生杀灭肝炎病毒的各种免疫细胞;CTL及其活性代谢产物诱导人体产生细胞杀伤性T淋巴细胞及自然杀伤细胞(NK),利用人体自身的免疫机能来攻击和消灭肝炎病毒,避免了传统的抗病毒药物停药后反弹的弊病。
2、免疫诱导作用:诱导机体产生多种抗病毒细胞因子(如各种内源性干扰素、白细胞介素、粒细胞刺激因子和转化生长因子)终杀灭病毒。
3、激活机体中性粒细胞,增强粒细胞的吞噬功能,穿透肝炎病毒的蛋白质膜,裂解肝炎病毒DNA分子链,破坏DNA病毒复制的模板,抑制病毒的复制。
4、促进病毒受感染细胞的抗原性表达,快速识别并锁定已经变异的病毒进行围剿清除。
二CTL细胞的直接杀伤靶细胞作用
2.细胞调亡特征及其发生机制
(1)细胞调亡的主要特征
凋亡细胞在形态上可见胞膜起泡、胞质紧缩,核染 色质凝聚,细胞碎裂或膜包绕的调亡小体。生化变化表 现为DNA在核小体之间断裂成180~200bp的多重片段。 (2)细胞凋亡发生的主要机制
靶细胞发生凋亡与CTL细胞从释放穿孔素(PF)、颗粒 酶等有关。PF在Ca2+存在下,插入靶细胞膜上,多个PF聚 合成一个空心管道,此时颗粒酶从孔中进入细胞,诱导 凋亡抗原 (Fas) 的表达,后者与 CTL 表面的 FasL( 配体 ) 结 合,激活了内源性DNA内切酶,使核小体断裂,最终导致 细胞死亡。
二、CTL细胞的直接杀伤靶细胞作用
细胞毒性T细胞(CTL)主要作用是直接杀伤靶细胞, 杀伤机制是穿孔素/颗粒酶系统和Fas/FasL系统作用。
1.靶细胞溶解过程
在体外观察CLT杀伤靶细胞过程,可分三个时相: (1) 接触相: CLT 细胞通过 TcR 与靶细胞上抗原 -MHC 复 合体结合,同时还需细胞粘附分子相互配对,此阶段还需 Mg2+和37C,此过程只需作用数分钟。 (2)打击相:CLT细胞粘附在靶细胞后,可见胞质嗜天 青蓝颗粒向靶细胞膜集中,并外吐释放颗粒,约 10min , 靶细胞膜被打成许多小孔。此时相是Ca2+和ATP依赖性的, 微管和微丝要发生收缩。 (3)裂解相:当CTL离开后,靶细胞发生一系列不可逆 变化而产生调亡。调亡是受基因控制的单个细胞自杀过程, 又称程序性细胞死亡(programmed cell death,PCD)。
ctl杀伤实验原理过程
ctl杀伤实验原理过程
CTL(Cytotoxic T Lymphocyte)杀伤实验是一种常用的实验方法,用于研究免疫细胞对于靶细胞的杀伤作用。
下面是 CTL 杀伤实验的原理和过程的详细解释:
原理:
CTL 是一类免疫细胞,具有特异性杀伤作用,可以识别并杀伤感染或突变的细胞。
CTL 杀伤实验的原理是将被测细胞(通常是肿瘤细胞或感染的细胞)与 CTL 细胞共培养,通过测量被杀伤的靶细胞数量或活性,来评估 CTL 的杀伤能力。
过程:
1. 准备靶细胞,选择合适的靶细胞,通常是肿瘤细胞或感染的细胞。
这些细胞需要与 CTL 细胞具有相应的抗原表达,以便 CTL 细胞能够识别并杀伤它们。
靶细胞可以通过培养或采用已建立的细胞系获得。
2. 准备 CTL 细胞,从免疫动物(如小鼠)或人体中获得 CTL
细胞。
这些 CTL 细胞可以通过刺激免疫细胞、体外扩增或采用已建立的细胞系获得。
3. 共培养,将靶细胞和 CTL 细胞一起共同培养。
通常,将它们以一定比例混合在培养基中,使它们相互作用。
4. 杀伤检测,在一定时间后,从共培养的细胞中取样,使用适当的方法检测杀伤效果。
常用的检测方法包括流式细胞术、细胞毒性试验、放射性标记等。
5. 数据分析,根据杀伤检测的结果,计算出 CTL 细胞对靶细胞的杀伤率或活性。
这可以通过比较共培养组和对照组的差异来确定。
总结:
CTL 杀伤实验的原理和过程主要涉及到选择合适的靶细胞和CTL 细胞、共培养、杀伤检测以及数据分析。
通过这些步骤,可以评估 CTL 细胞的杀伤能力,从而深入了解免疫细胞的功能和抗肿瘤或抗感染的机制。
tdcc,t细胞杀伤实验原理
T细胞杀伤实验,也称为细胞毒性实验,是一种用于评估T细胞免疫反应的实验。
这种实验的原理是评估T细胞对目标细胞的毒性或杀伤作用,通常在研究和诊断免疫相关疾病、肿瘤疫苗研发和药物筛选等领域中使用。
细胞毒性T细胞(CTL)是特异性细胞免疫的主要效应细胞之一,一般指CD8+T细胞,可特异而高效地杀伤靶细胞,参与抗病毒免疫、抗肿瘤免疫和移植排斥反应。
它对靶细胞的杀伤首先基于对靶细胞表面特异性抗原的识别,CTL可以通过其TCR识别靶细胞表面的抗原肽-MHC复合物,其中抗原肽可来自肿瘤抗原、病毒抗原或自身抗原。
识别后,CTL通过脱颗粒和直接接触杀伤靶细胞,外周血淋巴细胞包含针对不同抗原的特异性CTL克隆,在体外经某一特定(或同种异体细胞)抗原刺激后,能识别该抗原的T细胞克隆被选择性激活、增殖,而其他T细胞克隆则逐渐死亡;经3-4次刺激后,存活的细胞为识别MHC-特异性抗原肽复合物的细胞即抗原特异性CTL。
细胞毒性T细胞对靶细胞杀伤的机制是通过释放的穿孔素-颗粒酶系统介导的溶靶细胞作用或通过Fas/FasL系统介导的细胞凋亡作用。
ctl细胞全称核心标记
ctl细胞全称核心标记CTL细胞全称为Cytotoxic T Lymphocyte,是一种重要的免疫细胞。
它们能够通过特异性识别和杀伤感染体内的病原微生物或肿瘤细胞,从而保护机体免受感染和癌症等疾病的侵袭。
一、CTL细胞的结构和功能1. CTL细胞的结构CTL细胞是一种淋巴细胞,具有球形或卵圆形的形态。
它们表面有许多受体,包括T细胞受体(TCR)、CD8分子等。
此外,CTL细胞还可以分泌多种免疫因子,如干扰素(IFN-γ)、肿瘤坏死因子(TNF-α)等。
2. CTL细胞的功能CTL细胞主要通过两种方式发挥作用:直接杀伤和诱导凋亡。
直接杀伤:CTL细胞能够通过其表面的TCR与MHC-I分子上呈现的抗原肽结合,并释放出多种蛋白酶、穿孔素等物质,直接杀伤感染体内的病原微生物或肿瘤细胞。
诱导凋亡:CTL细胞还能够分泌多种免疫因子,如干扰素(IFN-γ)、肿瘤坏死因子(TNF-α)等,诱导感染体内的病原微生物或肿瘤细胞凋亡。
二、CTL细胞的产生和分化CTL细胞的产生和分化经历了一系列复杂的过程,包括:1. T细胞受体(TCR)基因重排:在胸腺中发生,用以产生不同的TCR结构。
2. 活化:当T细胞受体与MHC-I分子上呈现的抗原肽结合时,会激活T细胞并引发其增殖。
3. 分化:活化后的T细胞会分化成CTL细胞,并开始表达CD8分子,从而具有直接杀伤和诱导凋亡的能力。
4. 存活和记忆:部分CTL细胞会存活下来,并形成记忆性CTL细胞。
这些记忆性CTL细胞能够长期存活在机体内,并在再次遇到相同抗原时迅速作出反应。
三、CTL细胞与免疫应答1. CTL细胞的作用CTL细胞主要通过直接杀伤和诱导凋亡的方式,清除机体内的病原微生物或肿瘤细胞。
在免疫应答中,CTL细胞是一种非常重要的免疫细胞。
2. CTL细胞的识别和选择性杀伤CTL细胞能够通过其表面的TCR与MHC-I分子上呈现的抗原肽结合,并选择性地杀伤感染体内的病原微生物或肿瘤细胞。
杀伤检测原理
杀伤检测的原理主要基于细胞杀伤能力与细胞状态的关系。
细胞杀伤能力是CTL细胞和NK细胞特有的细胞功能,这两种细胞都可以表达诱导细胞凋亡的配体、分泌诱导细胞凋亡的细胞因子、分泌细胞毒性分子、诱导病毒感染细胞和肿瘤细胞的死亡。
检测方法有:活细胞线粒体中的琥珀酸脱氢酶能使外源性的MTT还原为水不溶性的蓝紫色结晶甲瓒,并沉积在细胞中,而死细胞无此功能,通过测定靶细胞代谢活性的减少来反映效应细胞所致的靶细胞的死亡。
此方法的优点是简单易操作,无需标记靶细胞,可以高通量实验,同时还可以测量细胞增殖活性。
缺点是此方法为间接法,与细胞状态关系比较大,容易出现假阴性。
如果样本有微生物污染则可导致假阳性结果。
LDH释放法:乳酸脱氢酶(LDH)是活细胞胞浆内含酶之一,在正常情况下,不能透过细胞膜。
当细胞受到损伤时,LDH可以透过细胞膜释放到培养基中。
释放出来的LDH在催化乳酸生成丙酮酸的过程中,使氧化型辅酶I(NAD+)变成还原型辅酶I (NADH2),后者再通过递氢体-吩嗪二甲酯硫酸盐(PMS)还原碘硝基氯化氮唑蓝(INT)或硝基氯化四氮唑蓝(NBT)形成有色的甲簪类化合物,在490nm或570nm波长处有一高吸收峰,利用酶标仪读取的OD值,即可测得杀伤细胞的活性。
此方法属于间接法。
虽然方法比较简单,可测的通量比较高,成本也相对比较低。
但是也存在许多不足之处,例如如果存在效应细胞状态不好,会出现数据重复性不好,数据结果不稳定,这个细胞状态与个体差异及冻存复苏等均有比较大关系;LDH可能存在部分自发释放现象,导致结果出现假阳性等。
报告基因转染法:利用基因转染技术将原核或真核生物的报告酶如β-半乳糖苷酶(β-galactosidase, β-gal)或荧光素酶(luciferase, luc)基因转染靶细胞,建立稳定转染靶细胞系,以此测定细胞杀伤效应。
通过测定释放入培养液中报告酶活性(代表靶细胞死亡数目),便可计算出效应细胞杀伤靶细胞的百分率。
ctl反应
ctl反应(CTL)反应,其特征是单个细胞的增殖能力、细胞因子分泌和细胞毒性功能逐渐下降。
这种反应模式,通常被称为T细胞耗竭。
识别突变肿瘤新抗原的CTL也发挥不同程度的免疫控制作用,但与慢性病毒感染中的CTL类似,处于低功能状态。
初始T细胞,主要分为CD4+T细胞和CD8+T细胞,根据它们在细胞表面存在的蛋白质而定,正是不同的分类决定了T细胞的毒性。
CD8+T细胞也称为细胞毒性T细胞或细胞毒性淋巴细胞(CTL),其细胞表面标志为CD3+,CD4+,CD8+,TCRaβ,它主要通过识别特异性抗原和I类MHC分子的肿瘤细胞,并杀伤这些肿瘤细胞,在防止一些淋巴系统的肿瘤及杀伤某些抗原调变的肿瘤细胞变异株具有一定的意义。
CD4+T细胞又分为四个主要子集TH1,TH2,TH17和Treg,其中“TH”表示“T辅助细胞”。
它们产生并分泌能够警告和激活其他免疫细胞的分子,TH2细胞通过提醒B细胞,粒细胞和肥大细胞,对于协调针对细胞外病原体(例如蠕虫)的免疫反应非常重要。
TH17细胞因其产生白介素17(IL-17)的能力而得名,IL-17是激活免疫和非免疫细胞的信号分子。
TH17细胞对于募集中性粒细胞很重要。
此时的它们主要在淋巴结之间巡逻、监视,一旦被抗原递呈细胞活化,前者可快速分化为效应T(Effector T Cell)或调节T (Suppressor T cell);后者可分化为细胞毒性T(cytotoxic T cell)和记忆T(Memory T Cell)。
T细胞的种类繁多,这也决定了它的多样性,才能在对抗病毒、肿瘤细胞时能够有更多的靶点选择,为癌症的免疫治疗发挥积极意义。
T细胞按照功能和表面标志可分成很多种类:•辅助性T细胞(Helper T cell),这是最大的一个T细胞亚群,下面分类众多,功能各异。
其功能主要是呈递处理过的抗原,给细胞毒性T细胞和B细胞传递信号。
•细胞毒性T细胞(cytotoxic T cell),听名字就知道是T细胞中的大哥了,可以反复对靶细胞进行杀伤并且自身不受损,它主要有两把厉害武器,通过分泌穿孔素和颗粒酶来杀死被感染的细胞或突变的细胞。
细胞毒实验的分类原理性检测方法与应用上课课堂
最大释放均值(Max)=最大释放孔cpm均值-最大释放对照孔cpm均值 自发释放均值(S自发)=自发释放孔cpm均值-培养基对照孔cpm均值
无菌取脾 研磨成单细胞悬液+2ml 1640
(无FBS)
细胞计数 【?/ml】 取20ul细胞+980ul的1640 混匀后取出20ul细胞+20ul台盼蓝
操作流程
行测定。
• 因此多年来人们一直试图寻找可以替代51Cr释放法的 CTL活性测定方法,如采用荧光标记、流式细胞分析 和报告基因等技术的灵敏可靠、简单易行的非同位素 测定法。
MTT(或MTS)还原法
本法根据细胞代谢活动与活细胞数直接成比例的原理,通过测定靶细 胞代谢活性的减少来反映效应细胞所致靶细胞的死亡。氧化型MTT进 入细胞后被线粒体脱氢酶还原生成蓝色formazan颗粒,经溶剂溶解后 比色定量,其颜色深浅直接与活细胞数有关,与靶细胞对照孔比较可 计算效应细胞杀伤靶细胞%。本法简便易行,无需预标靶细胞,与 51Cr释放法比较相关性好,还可测定淋巴细胞增殖活性和NK细胞活性。 MTT类似物MTS在细胞内还原的formazan产物具有水溶性,性质较稳定, 其测定简单快捷,特别适合于大批量测定。微生物污染可导致本法假 阳性结果。
验记录本上。
要对结果进行分析,写出影响结果的因素,及注意事项。
SI
50 40 30 20 10
0 100:1
Excel 作 图
NK杀伤实验
50:1 E:T
25:1
检测方法
1.1.1 alamarBlue一步荧光测定法 alamarBlue为活细胞代谢指示剂,易溶于水,进入细胞后经线粒体
酶促还原产生荧光及颜色变化,可用以定量。本法与51Cr释放法纺织 厂较有以下特点:①特异性相当但灵敏度更高,重复性好,组内及组 间差异很小。②使用方便,无需预先标记靶细胞及离心和洗涤步骤, 适用于大批量样品的高准确性自动测定。③alamarBlue的使用浓度不 影响细胞正常代谢及基因表达,可在无菌条件下测定后继续培养扩增 细胞,有利于对培养细胞的连续监测及深入研究。④还可测定淋巴细 胞增殖或化学物质的细胞毒性及细胞凋亡。⑤多种粘附或非粘附细胞 系、细菌、真菌等可用作靶细胞,所需效应细胞数较少(3×105/孔 即可)。⑥含胎牛血清(FCS)及酚红的培养液也不干扰测定结果
CTL诱导及杀伤实验
一、抗原肽诱导CTL制备1.PBMCs were separated from the whole blood of HLA-A2+ healthy controls. PBMCs (2 x106/ml) were cultured with each of the HLAA* 0201 refolding peptides at a concentration of 10 uM in RPMI 1640 medium containing 10% FCS and 20 U/ml recombinant human IL-2 (rhIL-2) in 24-well culture plate. Half of the medium was changed at day 4 with supplementation of rhIL-2 at 20 U/ml. At day 7, cells were harvested and tested for the presence of peptide-specific CD8+ T cells by an IFN-γrelease ELISPOT assay.---------------Zhou M, Xu D, Li X, Li H, Shan M, Tang J, Wang M, Wang FS, Zhu X, Tao H et al: Screening and identification of severe acute respiratorysyndrome-associated coronavirus-specific CTL epitopes. J Immunol2006,177(4):2138-2145.2. PBMCs were separated from heparinized venous blood by Ficoll-Hypaque density gradient centrifugation from HLAA*0201 normal donors and HCC patients. DCs were generated from peripheral blood monocytes as described by Romani. Briefly, PBMCs were seeded into six-well culture plates containing 3 ml RPMI-1640 and 10% FCS at5–10x106/well. Plates were incubated in a 37o C incubator for 2 h, then the non-adherent cells were removed and the adherent cells were cultured at 37o C in RPMI-1640 supplemented with 10% FCS, 1000 U/ml human recombinant GM-CSF and 500 U/ml human recombinant IL-4. All T cell stimulation was with day 7 DCs. As described below, DCs were matured with lipopolysaccharide (LPS) on day 6 and HCA587 antigen was added for effective processing at this time.Day 6 DCs were resuspended in RPMI-1640 with 1000 U/ml GM-CSF, 500 U/ml IL-4 and 10 ng/ml LPS and incubated at 37 o C. After 24 h cultivation the DCs were collected, washed and pulsed with 10 m g/ml HCA587 peptide for 3 h at 37 o C. The DCs were washed twice for the following stimulation.CD8+T cells were isolated by positive selection with CD8-Dynal immunomagnetic beads according to the manufacturer’s instructions.After washing, CD8+T cells were co-cultured with HCA587peptide-loaded DCs in 2 ml RPMI-1640 mediumsupplemented with 10% AB serum, recombinant human IL-2(10 ng/ml) and IL-6 (500 U/ml). Seven days later, the cultured T cells were restimulated with freshly prepared peptide-pulsed DCs and cultured for another 7 days. After four consecutive rounds of stimulation, cultures were tested for the presence of HCA587-specific CTLs. -----------Li B, Wang Y, Chen J, Wu H, Chen W: Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587. Clin Exp Immunol2005, 140(2):310-319.3.Generation of CTLs in PBMCs from healthy donors:Dendritic cells (DCs) have the unique capacity of activating naive T cells and initiating primary T-cell response. Antigen-specific T-cell responses from peripheral blood mononuclear cells (PBMCs) can be elicited with antigenic peptide-pulsed autologous DCs. We obtained PBMCs from the buffy coat of heparinized whole blood samples of healthy donors by density gradient centrifugation on the Histopaque 1077. These cells were resuspended in serum-free RPMI 1640 and allowed to adhere to six well plates at a final concentration of 1 x 107cells/3 ml/ well. After 2 h of incubation at 37°C, non-adherent cells were gently removed with warm medium by gently pipetting. The non-adherent cells (effector lymphocytes) were cryopreserved in FCS supplemented by 10% DMSO. The resultant adherent cells containing DCs were cultured in medium supplemented with 800 U/ml GMCSF and 1,000 U/ml IL-4 in 37°C/5% CO2. Every 2 days, one-half of the medium was replaced by fresh medium containing a double concentration of GM-CSF and IL-4 as indicated above. On day 5, 10 ng/ml of recombinant human tumor necrosis factor a (TNF-a) was added to the medium to induce phenotypic and functional maturation of DCs. After 48 h, DCs were pulsed with 20 ug/ml peptide in the presence of 3 ug/ml b2- microglobulin at 37°C for 3 h and irradiated at 30 Gy before use. The thawed 2 x106 of non-adherent effector lymphocytes were cocultured with 2 x105 peptidepulsed irradiated autologous DCs in a 24-well plate in the presence of 10 ng/ml recombinant human interleukin-7 (IL-7). After 7 days, lymphocytes were restimulated with peptide-pulsed autologous PBMCs in medium containing 10 ng/ml IL-7 and 20 U/ml IL-2. About 20 U/ml of IL-2 was added 24 h later at regular intervals, 2 days after each restimulation. Lymphocytes were restimulated each week in the same manner. On the seventh day, after the three rounds of restimulation, cells were harvested and tested by ELISPOT assay.--------------An altered peptide ligand for nave cytotoxic T lymphocyte epitope of TRP-2(180–188) enhanced immunogenicity.Cancer Immunol Immunother (2007) 56:319–329 第三军医大吴玉章4.Generation of CTLs in healthy donorsDendritic cells are characterized by the unique capacity to activate naive T cells and initiate primary T-cell response. Antigen-specific T-cell responses from peripheral blood mononuclear cells (PBMCs) can be elicited with antigenic peptide- or protein-pulsed autologous DCs. Here, PBMCs were isolated from whole blood of 11 healthy HLA-A2.1_ volunteer donors by Ficoll/Hypaque density gradient centrifugation. Human peripheral blood monocyte-derived DCs were generated as previously described by us. On day 5 of culture, 10 ng/mL recombinant human tumor necrosis factor was added to the medium to induce phenotypic and functional maturation. Then, 48 hours later, DCs were pulsed with 20 ug/mL peptide in the presence of 3 ug/mL B2-microglobulin at 37°C for 3 hours and irradiated at 30 Gy before use. Peripheral blood lymphocytes (PBLs, 2 x106) were cocultured with 2 x 105peptide-pulsed irradiated autologous DCs in a 24-well plate in the presence of 10 ng/mL recombinant human interleukin-7. The next day, recombinant human IL-10 was added to the culture medium, to give a final concentration of 10 ng/mL. After 7 days, lymphocytes were restimulated with peptide-pulsed irradiated autologous DCs in medium containing 10 ng/mL IL-7 and 10 ng/mL IL-10, and then supplemented with 20 IU/mL IL-2 24 hours later. Lymphocytes were restimulated each week in the same manner. At 7 days after the fourth round of restimulation, cells were harvested and tested by ELISPOT assay, cytotoxicity assay, and tetramer staining. CD8T lymphocytes were purified by CD4_ cell–negative depletion using human CD4 microbeads.---------Wang B, Chen H, Jiang X, Zhang M, Wan T, Li N, Zhou X, Wu Y, Yang F, Yu Y et al: Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.Blood2004, 104(1):200-206.第二军医大曹雪涛5. 抗原肽诱导CTL制备:密度梯度离心法分离经EDAT抗凝的静脉血中的外周血单个核细胞(peripheral blood mononuclear cells,PBMC),分离得到的PBMC种于6孔细胞培养板,在含10%FCS的RPMI1640培养基中,37℃5%CO2孵育1.5h。
体外活性实验
体外活性试验相关知识以健康人外周血单核细胞为前体细胞,体外诱导其为树突状细胞(DC ),分别负载多肽抗原,产生特异性细胞毒性T 淋巴细胞(CTL ),以探讨其对靶细胞的杀伤作用。
抗原肽诱导CTL 制备:① 外周血单核细胞(PBMC )的分离:分别选取(经BCG 免疫,PPD 阳性)HLA-A2.1+、HLA-A3+ 人抗凝外周全血,通过淋巴细胞分离液分离获得PBMC 。
② 树突状细胞的诱导:将PBMC 在24孔板中贴壁培养,分离贴壁的单核细胞,每孔加含FBS 、GM-CSF 和IL-4的1640培养基,于37℃、5%CO2孵箱中,培养至第5天加LPS 诱导成熟,用相差显微镜观察DC 诱导培养过程中的细胞形态学变化。
通过流式细胞术检测CD1a 、CD83、CD80、HLA-DR 的表达。
③ 细胞毒T 淋巴细胞(CTL )的体外诱导:DC 诱导至第5天,加入待测肽,第7天收获DC 。
于24孔板中加入用免疫磁珠分选的CD8+ T 淋巴细胞作为反应细胞,DC 作为刺激细胞,第2天加IL-2,置37℃、5%CO2饱和湿度条件下培养。
用肽负载的DC 按前述方法再重复刺激3次。
收获CTL 用于检测。
细胞毒性分析:④细胞毒活性检测:CTL杀伤实验用MTT法和4小时51Cr释放法。
以抗原肽诱导CTL为效应细胞(E),负载抗原肽的T2细胞作为靶细胞(T)。
MTT法按效靶比20:1加入96孔板中,靶细胞每孔1×103个,设单独靶细胞孔和单独CTL孔,每组3复孔,每孔200 μL。
37 ℃、5 %CO2孵育48 h后,加入MTT 0.2 mg/孔,继续培养4-6 h,去上清,加入DMSO 100 μL/孔,显色,酶标仪于波长570 nm下读数。
按以下公式计算杀伤率。
同时以不相关肽诱导的CTL作为阴性对照。
杀伤率=[1-(试验孔A值-效应细胞孔A值)/靶细胞孔A值]×100% 4h51Cr释放法MTT 实验中与阴性对照比较杀伤作用存在显著性差异的候选肽使用更精确的4h51Cr 释放法来验证。
对于诱导细胞毒T淋巴细胞
摘要:对于诱导细胞毒T淋巴细胞(CTL)的可靠和有效的方法一直是研究的热点,本次试验主要在于动物模型的研究,这种动物模型允许测试新颖的疫苗策略并且最终实现一个更有效率的临床试验的计划。
在这里, 由一串部分重叠的CTL表位(20个人,3只猕猴和1只老鼠)传递和表达人类免疫缺陷病毒(HIV)疫苗候选人被创建通过使用质体DNA和被修改病毒安卡拉(MV A;一个衰减痘苗病毒),它们是两种可接受的疫苗工具为了在人类使用。
在老鼠中,在单一的静脉肌肉注射后这些疫苗被表现诱导病毒特异性干扰素r的产生和细胞毒CD8+T细胞,随着免疫试验方案被寻找来提高诱导特异性的HIV的T细胞水平,DNA首要的-MVA的提升被发现作为最有力的试验方案,这种多态表位的DNA也引出CTL 当用Accell® 基因枪传递装置在细胞内传送。
基因传递装置(基因枪),最后,一个组合的内部的基因枪DNA–MVA 疫苗方法诱导在猕猴高频率的循环CTL,这种高频率CTL与在猴子所观察到的猿类免疫缺陷病毒(SIV)感染的猴子。
对这种方法的优化在非人类的灵长类也正在进行,因此,为了有效的引出CTL一个免疫的方法已经被发现,这种方法很可能促进这些淋巴细胞在控制SIV和HIV 感染中起评价的作用。
关键词:HIV疫苗;CTL多态位;DNA 首要的MV A的提高1.引言一个有效的疫苗是最希望来控制获得性免疫缺陷病综合症(AIDS)的恐慌。
通过保护免疫组织不被人体免疫缺陷病毒(HIV)感染的这种疫苗将起帮助的作用,尽管一个HIV疫苗可能诱导CD8+和CD4+ T 细胞的反应,以及中和抗体,但是缺乏这些诱导的人群中也能说明这些组成成分在保护中的作用。
对于这种方法最主要的障碍是在于识别足够地高的CD8+T 细胞的反应,和识别抗体中和最初的HIV分离。
识别这些反应的疫苗作为重大进展朝着预防HIV感染或衰减它的方向,从而长期地延缓HIV的发作。
CD8 +T细胞在参与机体的防御不止一个方面:它们通过杀伤被感染的细胞来阻止病毒的繁殖,和分泌一系列的细胞因子如IFN-r和肿瘤坏死因素,直接或间接有助于控制病毒的感染。
ctl效应细胞的制备
ctl效应细胞的制备一、引言CTL(Cytotoxic T Lymphocyte)效应细胞是免疫系统中的重要成分,它在抗体介导的免疫应答之外,起着关键的作用。
因此,研究CTL效应细胞的制备方法对于深入了解免疫应答机制和开发新的免疫治疗手段具有重要意义。
二、CTL效应细胞的制备方法1. 初代细胞培养要制备CTL效应细胞,首先需要从外周血或淋巴组织中获得淋巴细胞。
这些淋巴细胞可以通过密度梯度离心法分离出来,然后在培养基中进行初代细胞培养。
培养基中通常添加适当浓度的IL-2(Interleukin-2),以促进淋巴细胞的生长和增殖。
2. 抗原刺激在细胞培养的早期阶段,可以通过添加特定的抗原刺激淋巴细胞,以诱导CTL效应细胞的生成。
这些抗原可以是蛋白质抗原、多肽抗原或肿瘤细胞提取物等。
抗原刺激会激活淋巴细胞,并诱导它们分化为CTL效应细胞。
3. 细胞扩增为了获得足够数量的CTL效应细胞,需要对刺激后的淋巴细胞进行扩增。
可以通过多次刺激和培养的方法,使淋巴细胞不断分裂增殖。
在细胞扩增的过程中,需要定期补充培养基和IL-2,以提供充足的营养和生长因子。
4. 细胞分选经过细胞扩增后,可以使用流式细胞仪等技术对CTL效应细胞进行分选。
流式细胞仪可以根据细胞的表面标志物或功能特性,将CTL 效应细胞与其他细胞分开。
这样可以提高CTL效应细胞的纯度,并减少其他细胞对实验结果的干扰。
5. 功能检测需要对制备的CTL效应细胞进行功能检测。
常用的方法包括细胞毒性试验、细胞因子释放试验等。
这些试验可以评估CTL效应细胞对靶细胞的杀伤能力和细胞因子的产生能力。
三、应用前景CTL效应细胞的制备方法不仅可以用于研究免疫应答机制,还可以应用于临床治疗。
通过提取患者自身的CTL效应细胞,经过扩增和分选后,再重新注入患者体内,可以增强患者的免疫反应,提高对肿瘤和病原体的清除能力。
这种免疫治疗手段已经在某些肿瘤类型中取得了显著的疗效。
四、结论CTL效应细胞的制备是一项复杂的工作,需要经过多个步骤和严格的操作。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
一、抗原肽诱导CTL制备1.PBMCs were separated from the whole blood of HLA-A2+ healthy controls. PBMCs (2 x106/ml) were cultured with each of the HLAA* 0201 refolding peptides at a concentration of 10 uM in RPMI 1640 medium containing 10% FCS and 20 U/ml recombinant human IL-2 (rhIL-2) in 24-well culture plate. Half of the medium was changed at day 4 with supplementation of rhIL-2 at 20 U/ml. At day 7, cells were harvested and tested for the presence of peptide-specific CD8+ T cells by an IFN-γrelease ELISPOT assay.---------------Zhou M, Xu D, Li X, Li H, Shan M, Tang J, Wang M, Wang FS, Zhu X, Tao H et al: Screening and identification of severe acute respiratorysyndrome-associated coronavirus-specific CTL epitopes. J Immunol2006,177(4):2138-2145.2. PBMCs were separated from heparinized venous blood by Ficoll-Hypaque density gradient centrifugation from HLAA*0201 normal donors and HCC patients. DCs were generated from peripheral blood monocytes as described by Romani. Briefly, PBMCs were seeded into six-well culture plates containing 3 ml RPMI-1640 and 10% FCS at5–10x106/well. Plates were incubated in a 37o C incubator for 2 h, then the non-adherent cells were removed and the adherent cells were cultured at 37o C in RPMI-1640 supplemented with 10% FCS, 1000 U/ml human recombinant GM-CSF and 500 U/ml human recombinant IL-4. All T cell stimulation was with day 7 DCs. As described below, DCs were matured with lipopolysaccharide (LPS) on day 6 and HCA587 antigen was added for effective processing at this time.Day 6 DCs were resuspended in RPMI-1640 with 1000 U/ml GM-CSF, 500 U/ml IL-4 and 10 ng/ml LPS and incubated at 37 o C. After 24 h cultivation the DCs were collected, washed and pulsed with 10 m g/ml HCA587 peptide for 3 h at 37 o C. The DCs were washed twice for the following stimulation.CD8+T cells were isolated by positive selection with CD8-Dynal immunomagnetic beads according to the manufacturer’s instructions.After washing, CD8+T cells were co-cultured with HCA587peptide-loaded DCs in 2 ml RPMI-1640medium supplemented with 10% AB serum, recombinant human IL-2(10 ng/ml) and IL-6 (500 U/ml). Seven days later, the cultured T cells were restimulated with freshly prepared peptide-pulsed DCs and cultured for another 7 days. After four consecutive rounds of stimulation, cultures were tested for the presence of HCA587-specific CTLs.-----------Li B, Wang Y, Chen J, Wu H, Chen W: Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587. Clin Exp Immunol2005, 140(2):310-319.3.Generation of CTLs in PBMCs from healthy donors:Dendritic cells (DCs) have the unique capacity of activating naive T cells and initiating primary T-cell response. Antigen-specific T-cell responses from peripheral blood mononuclear cells (PBMCs) can be elicited with antigenic peptide-pulsed autologous DCs. We obtained PBMCs from the buffy coat of heparinized whole blood samples of healthy donors by density gradient centrifugation on the Histopaque 1077. These cells were resuspended in serum-free RPMI 1640 and allowed to adhere to six well plates at a final concentration of 1 x 107cells/3 ml/ well. After 2 h of incubation at 37°C, non-adherent cells were gently removed with warm medium by gently pipetting. The non-adherent cells (effector lymphocytes) were cryopreserved in FCS supplemented by 10% DMSO. The resultant adherent cells containing DCs were cultured in medium supplemented with 800 U/ml GMCSF and 1,000 U/ml IL-4 in 37°C/5% CO2. Every 2 days, one-half of the medium was replaced by fresh medium containing a double concentration of GM-CSF and IL-4 as indicated above. On day 5, 10 ng/ml of recombinant human tumor necrosis factor a (TNF-a) was added to the medium to induce phenotypic and functional maturation of DCs. After 48 h, DCs were pulsed with 20 ug/ml peptide in the presence of 3 ug/ml b2- microglobulin at 37°C for 3 h and irradiated at 30 Gy before use. The thawed 2 x106 of non-adherent effector lymphocytes were cocultured with 2 x105 peptidepulsed irradiated autologous DCs in a 24-well plate in the presence of 10 ng/ml recombinant human interleukin-7 (IL-7). After 7 days, lymphocytes were restimulated with peptide-pulsed autologousPBMCs in medium containing 10 ng/ml IL-7 and 20 U/ml IL-2. About 20 U/ml of IL-2 was added 24 h later at regular intervals, 2 days after each restimulation. Lymphocytes were restimulated each week in the same manner. On the seventh day, after the three rounds of restimulation, cells were harvested and tested by ELISPOT assay.--------------An altered peptide ligand for nave cytotoxic T lymphocyte epitope of TRP-2(180–188) enhanced immunogenicity.Cancer Immunol Immunother (2007) 56:319–329 第三军医大吴玉章4.Generation of CTLs in healthy donorsDendritic cells are characterized by the unique capacity to activate naive T cells and initiate primary T-cell response. Antigen-specific T-cell responses from peripheral blood mononuclear cells (PBMCs) can be elicited with antigenic peptide- or protein-pulsed autologous DCs. Here, PBMCs were isolated from whole blood of 11 healthy HLA-A2.1_ volunteer donors by Ficoll/Hypaque density gradient centrifugation. Human peripheral blood monocyte-derived DCs were generated as previously described by us. On day 5 of culture, 10 ng/mL recombinant human tumor necrosis factor was added to the medium to induce phenotypic and functional maturation. Then, 48 hours later, DCs were pulsed with 20 ug/mL peptide in the presence of 3 ug/mL B2-microglobulin at 37°C for 3 hours and irradiated at 30 Gy before use. Peripheral blood lymphocytes (PBLs, 2 x106) were cocultured with 2 x 105 peptide-pulsed irradiated autologous DCs in a 24-well plate in the presence of 10 ng/mL recombinant human interleukin-7. The next day, recombinant human IL-10 was added to the culture medium, to give a final concentration of 10 ng/mL. After 7 days, lymphocytes were restimulated with peptide-pulsed irradiated autologous DCs in medium containing 10 ng/mL IL-7 and 10 ng/mL IL-10, and then supplemented with 20 IU/mL IL-2 24 hours later. Lymphocytes were restimulated each week in the same manner. At 7 days after the fourth round of restimulation, cells were harvested and tested by ELISPOT assay, cytotoxicity assay, and tetramer staining. CD8T lymphocytes were purified by CD4_ cell–negative depletion using human CD4microbeads.---------Wang B, Chen H, Jiang X, Zhang M, Wan T, Li N, Zhou X, Wu Y, Yang F, Yu Y et al: Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.Blood2004, 104(1):200-206.第二军医大曹雪涛5. 抗原肽诱导CTL制备:密度梯度离心法分离经EDAT抗凝的静脉血中的外周血单个核细胞(peripheral blood mononuclear cells,PBMC),分离得到的PBMC种于6孔细胞培养板,在含10%FCS的RPMI1640培养基中,37℃5%CO2孵育1.5h。